✦ LIBER ✦

Trough levels and antibodies to infliximab may not predict response to intensification of infliximab therapy in patients with inflammatory bowel disease

✍ Scribed by Benjamin Pariente; Guillaume Pineton de Chambrun; Roman Krzysiek; Marine Desroches; Gauthier Louis; Chiara De Cassan; Clotilde Baudry; Jean-Marc Gornet; Pierre Desreumaux; Dominique Emilie; Jean-Frédéric Colombel; Matthieu Allez

Book ID: 112101177
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 320 KB
Volume: 18
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.21839

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Infliximab trough levels may predict sus

Infliximab trough levels may predict sustained response to infliximab in patients with Crohn's disease

✍ Bortlik, Martin; Duricova, Dana; Malickova, Karin; Machkova, Nadezda; Bouzkova, 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 425 KB

P360 Infliximab trough levels may predic

P360 Infliximab trough levels may predict sustained response to infliximab in patients with Crohn's disease: A single cohort study

✍ M. Bortlik; D. Duricova; K. Malickova; A. Komarek; N. Machkova; E. Bouzkova; L. 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 49 KB

P569 Clinical correlations of infliximab

P569 Clinical correlations of infliximab trough levels (IFX-TL) and antibodies to infliximab (ATI) in inflammatory bowel disease

✍ Daperno, M.; Lavagna, A.; Fracchia, M.; Guiotto, C.; Germano, L.; Rigazio, C.; E 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 55 KB

Clinical Value of Measuring Trough Level

Clinical Value of Measuring Trough Levels and Human Anti-Chimeric Antibodies in Patients With Inflammatory Bowel Disease Who Lost Response to Infliximab Therapy

✍ Pariente, Benjamin ;Pineton de Chambrun, Guillaume ;Desroches, Marine ;De Cassan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 101 KB

P.06.20 ROLE OF TROUGH LEVELS AND ANTIBO

P.06.20 ROLE OF TROUGH LEVELS AND ANTIBODIES TO INFLIXIMAB IN THE EVALUATION OF LOSS OF RESPONSE AND INFUSION REACTIONS TO INFLIXIMAB THERAPY IN INFLAMMATORY BOWEL DISEASE

✍ Marzo, M.; Armuzzi, A.; Felice, C.; Pugliese, D.; Andrisani, G.; Tolusso, B.; Gr 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 851 KB

822 Mucosal Gene Signatures to Predict R

822 Mucosal Gene Signatures to Predict Response to Infliximab in Patients with Inflammatory Bowel Disease

✍ Ingrid Arijs; Leentje Van Lommel; Kristel Van Steen; Gert De Hertogh; Marc Ferra 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 75 KB